HUGE news for Treatment of MS - the first ever treatment for Primary Progressive MS is on the horizon. Positive Phase III clinical trial results just announced last night so should be submitted to the regulators for approval very soon. Also very effective in the more common relapsing-remitting MS.
First Data From Ocrelizumab Phase 3 Studies in MS
Genentech has released topline data from its three positive phase 3 studies of ocrelizumab in relapsing as well as progressive multiple sclerosis ahead of presentations this week at ECTRIMS 2015.